GGrantIndex
← Leaderboards

Roskamp Institute, Inc.

Sarasota, FL

Compare ↔
$16,372,529
Total funding
24
Grants

Funding over time

peak $1.7M · FY2006–25
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,372,529 · 24

By mechanism

R01$10,058,026 · 7
R21$3,530,030 · 8
R03$2,291,620 · 8
R56$492,853 · 1

Investigators at Roskamp Institute, Inc.

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Aurore Nkiliza$341,0001 gr

Emerging Leaders

6–10 yrs in

1Joseph O Ojo$2,672,3997 gr2Ghania Ait-Ghezala$400,0001 gr3Scott Allen Ferguson$162,0001 gr4Benoit Christian Mouzon$80,0001 gr

All-Time

Most funded here, all years

1Joseph O Ojo$2,672,3997 gr2Ghania Ait-Ghezala$400,0001 gr3Aurore Nkiliza$341,0001 gr4Scott Allen Ferguson$162,0001 gr5Benoit Christian Mouzon$80,0001 gr

Largest grants

Neurological effects of aerosolized red tide neurotoxins$704,695
R01 · FY2024 · ES
Neurological effects of aerosolized red tide neurotoxins$700,329
R01 · FY2025 · ES
Influence of APOE Genotype on the neurodegenerative sequelae of repetitive mild TBI in an hTau mouse model.$492,853
R56 · FY2019 · NS
Aberrant PTEN signaling in chronically activated microglia drives tau pathology, neurodegeneration and cognitive decline following repetitive brain injury$449,460
R21 · FY2024 · AG
Cerebrovascular contributions to APOE4-mediated brain bioenergetic deficits in Alzheimer's disease$449,460
R21 · FY2023 · AG
The role of PPARγ in astrocyte pathobiology after exposure to repetitive mild traumatic brain injury$449,444
R21 · FY2023 · AG
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY$400,000
R01 · FY2018 · NS
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY$400,000
R01 · FY2017 · NS
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY$400,000
R01 · FY2019 · NS
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY$400,000
R01 · FY2020 · NS
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY$400,000
R01 · FY2016 · NS
BACE1 regulation and TNFR Type II receptor in Alzheimers disease$388,750
R01 · FY2010 · AG
Activation of Atypical PKC by Insulin and Other Agonists$388,750
R01 · FY2011 · DK
BACE1 regulation and TNFR Type II receptor in Alzheimers disease$373,667
R01 · FY2011 · AG
BACE1 regulation and TNFR Type II receptor in Alzheimers disease$373,667
R01 · FY2014 · AG
BACE1 regulation and TNFR Type II receptor in Alzheimers disease$373,667
R01 · FY2012 · AG
BACE1 regulation and TNFR Type II receptor in Alzheimers disease$353,116
R01 · FY2013 · AG
Targeting the astrocyte-cerebrovasculature system to correct brain bioenergetics defects associated with APOE4$341,000
R03 · FY2025 · AG
Activation of Atypical PKC by Insulin and Other Agonists$332,006
R01 · FY2007 · DK
Activation of Atypical PKC by Insulin and Other Agonists$325,367
R01 · FY2008 · DK